Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anja Kaiser-Osterhues"'
Autor:
Reiner Sandner, Roland Schnell, Wolfgang Knauf, Mark-Oliver Zahn, TLN-Group, Leonora Houet, Anja Kaiser-Osterhues, Norbert Marschner, Susanne Tech, Michael Koenigsmann, Wolfgang Abenhardt, Christoph Maintz
Publikováno v:
Hematological Oncology
Owing to its heterogeneity and rarity, management of disseminated marginal zone B‐cell lymphoma (MZL) remains largely understudied. We present prospective data on choice of systemic treatment and survival of patients with MZL treated in German rout
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460c8a9cf4594798d596fdfddc2786a1
https://doi.org/10.1002/hon.2868
https://doi.org/10.1002/hon.2868
Autor:
Norbert, Marschner, Susanna, Hegewisch-Becker, Marcel, Reiser, Eyck, von der Heyde, Mathias, Bertram, Stephan H, Hollerbach, Stephan, Kreher, Thomas, Wolf, Adrian, Binninger, Marco, Chiabudini, Anja, Kaiser-Osterhues, Martina, Jänicke
Publikováno v:
International journal of cancerREFERENCES. 152(3)
There is no prospective, randomised head-to-head trial comparing first-line FOLFIRINOX and gemcitabine/nab-paclitaxel in advanced pancreatic cancer. We assess real-world effectiveness and quality of life (QoL) of both regimens using a new prognostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5dc8916ef3dc6ce6f1ad958a9fb7b668
https://pubmed.ncbi.nlm.nih.gov/36053905
https://pubmed.ncbi.nlm.nih.gov/36053905
Autor:
Leonora Houet, Burkhard Otremba, TLN-Group, Annette Sauer, Mark-Oliver Zahn, Anja Kaiser-Osterhues, Wolfgang Knauf, Norbert Marschner, Hans Rainer Slawik, Natalie Wetzel, Wolfgang Abenhardt, Ute Bückner
Publikováno v:
Hematological Oncology
Waldenström's macroglobulinaemia (WM) is a rare indolent B‐cell lymphoma for which only little prospective phase III evidence exists. Thus, real world data are important to provide insight into treatment and survival. We present here data on choic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83581ae0ee5651ce3009d4fee33bd2b4
https://doi.org/10.1002/hon.2740
https://doi.org/10.1002/hon.2740
Autor:
Mark-Oliver Zahn, Hans Rainer Slawik, Wolfgang Abenhardt, Ute Bückner, Annette Sauer, Natalie Wetzel, Anja Kaiser-Osterhues, Wolfgang Knauf, Leonora Houet, Burkhard Otremba, Norbert Marschner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a874c3eb6dd4f927a5de8621f638fe
https://doi.org/10.1002/hon.2740/v2/response1
https://doi.org/10.1002/hon.2740/v2/response1
Autor:
Martina Jänicke, Jacqueline Rauh, Johannes Mohm, Wolfgang Abenhardt, Anja Kaiser-Osterhues, Norbert Marschner, Johanna Harde, Wolfgang Knauf
Publikováno v:
European journal of haematologyREFERENCES. 103(5)
OBJECTIVES R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) is the standard therapy for patients with previously untreated diffuse large B-cell lymphomas (DLBCL). Dose-dense two-weekly 'R-CHOP-14' was not superior over three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3942e15704939b2b420dd28db8f552
https://pubmed.ncbi.nlm.nih.gov/31314918
https://pubmed.ncbi.nlm.nih.gov/31314918
Publikováno v:
Im Focus Onkologie. 20:42-44
Mit jahrlich etwa 500.000 Neuerkrankungen gehort Krebs zu den haufigsten Erkrankungen in Deutschland und ist die zweithaufigste Todesursache [1]. Wie sieht die Behandlung der Tumorpatienten in der Routineversorgung tatsachlich aus? Wie wirksam ist di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68cd39c21721377750506597aff1ea0f
https://doi.org/10.1007/s15015-017-3513-6
https://doi.org/10.1007/s15015-017-3513-6